We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Beckman Coulter Adopts Verification System

By Labmedica staff writers
Posted on 21 Jul 2006
The Artel MVS (multichannel verification system), developed by Artel (Westbrook, Maine, USA), has been adopted by Beckman Coulter (Fullerton, CA, USA), leading manufacturer of testing instrumentation, in order to verify the accuracy and precision of its automated liquid handling systems used in pharmaceutical and clinical laboratories. More...


A future option to the company's Biomek customers, the MVS will provide documentation about system performance, aiding labs to meet compliance and regulatory requirements. The MVS will be part of the company's Field Service Operational Qualification Program.

Because Biomek customers quickly generate data used in critical assays and due to increasing regulatory pressure governing process controls, Beckman Coulter wanted a more convenient method to measure instrument performance. Upgrading its Field Service Operational Qualification Program technology with the MVS, a rapid and traceable system, allows Beckman Coulter to easily meet customer demands for documented validation.

Artel's MVS allows us to rapidly assess the performance of our instruments in the field and provide documented, traceable data, notes Lisa Knapp, technical services manager for Beckman Coulter. This is especially important for some of our customers operating in regulated environments who need third-party validation of instrumentation and processes.

The MVS is based on proprietary ratiometric photometry, which measures light absorption by two specially formulated dyes in order to verify volume, making it especially effective at low volumes. In addition, the MVS can perform calibration very quickly, and can be applied to Beckman Coulter's full portfolio of Biomek liquid handlers, ranging from one to 384 channels.

The MVS is becoming the tool of choice for laboratory liquid delivery quality assurance, noted Ms. Knapp. We equipped our service representatives with a standard performance measurement tool so they can communicate in the same language with Artel's customers using the MVS on the bench, and this will streamline service visits. Robust and unaffected by environmental conditions, the MVS is portable and user-friendly, facilitating its use by service representatives in the field as well as by end-users for interim checks.



Related Links:
Artel
Beckman Coulter

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.